Loading...
Holdco Nuvo Group D.G Ltd. Warrants
NUVOW•NASDAQ
Healthcare
Medical - Devices
$0.005
$0.00(6.00%)

Over the past four quarters, Holdco Nuvo Group D.G Ltd. Warrants demonstrated steady revenue growth, increasing from $25.00 in Q1 2023 to $0.00 in Q4 2023. Operating income reached -$770320.00 in Q4 2023, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$770320.00, reflecting operational efficiency. Net income rose to -$100310.00, with EPS at -$0.008. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan